Kevin Fischbeck
Stock Analyst at B of A Securities
(3.93)
# 612
Out of 5,055 analysts
187
Total ratings
64.12%
Success rate
5.31%
Average return
Main Sectors:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARDT Ardent Health | Maintains: Underperform | $12 → $10 | $8.28 | +20.77% | 4 | Nov 13, 2025 | |
| HUM Humana | Maintains: Neutral | $280 → $300 | $234.11 | +28.14% | 17 | Oct 10, 2025 | |
| ELV Elevance Health | Maintains: Neutral | $330 → $370 | $330.91 | +11.81% | 4 | Oct 10, 2025 | |
| UNH UnitedHealth Group | Maintains: Neutral | $350 → $390 | $320.52 | +21.68% | 27 | Oct 8, 2025 | |
| AMN AMN Healthcare Services | Maintains: Underperform | $20 → $18 | $15.90 | +13.21% | 5 | Sep 10, 2025 | |
| DVA DaVita | Maintains: Underperform | $145 → $140 | $117.27 | +19.38% | 13 | Sep 10, 2025 | |
| THC Tenet Healthcare | Maintains: Buy | $205 → $225 | $192.40 | +16.94% | 7 | Sep 10, 2025 | |
| EHC Encompass Health | Maintains: Buy | $145 → $160 | $112.00 | +42.86% | 2 | Sep 10, 2025 | |
| CNC Centene | Downgrades: Underperform | $52 → $30 | $37.08 | -19.09% | 13 | Jul 16, 2025 | |
| UHS Universal Health Services | Downgrades: Underperform | $215 → $185 | $226.50 | -18.32% | 15 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $394 → $410 | $477.10 | -14.06% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $33 | $15.65 | +110.86% | 8 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $3 | $0.54 | +458.66% | 2 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $439 | $136.79 | +220.93% | 15 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6.5 | $9.33 | -30.33% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $16.04 | -54.80% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $271.33 | +28.99% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $15.06 | +198.80% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $3.01 | +82.72% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $12.74 | +174.73% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $2.35 | +325.53% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $11.64 | -35.57% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $28.11 | -35.97% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $23.02 | - | 3 | Sep 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $19 | $27.71 | -31.43% | 2 | Feb 9, 2018 |
Ardent Health
Nov 13, 2025
Maintains: Underperform
Price Target: $12 → $10
Current: $8.28
Upside: +20.77%
Humana
Oct 10, 2025
Maintains: Neutral
Price Target: $280 → $300
Current: $234.11
Upside: +28.14%
Elevance Health
Oct 10, 2025
Maintains: Neutral
Price Target: $330 → $370
Current: $330.91
Upside: +11.81%
UnitedHealth Group
Oct 8, 2025
Maintains: Neutral
Price Target: $350 → $390
Current: $320.52
Upside: +21.68%
AMN Healthcare Services
Sep 10, 2025
Maintains: Underperform
Price Target: $20 → $18
Current: $15.90
Upside: +13.21%
DaVita
Sep 10, 2025
Maintains: Underperform
Price Target: $145 → $140
Current: $117.27
Upside: +19.38%
Tenet Healthcare
Sep 10, 2025
Maintains: Buy
Price Target: $205 → $225
Current: $192.40
Upside: +16.94%
Encompass Health
Sep 10, 2025
Maintains: Buy
Price Target: $145 → $160
Current: $112.00
Upside: +42.86%
Centene
Jul 16, 2025
Downgrades: Underperform
Price Target: $52 → $30
Current: $37.08
Upside: -19.09%
Universal Health Services
Jul 16, 2025
Downgrades: Underperform
Price Target: $215 → $185
Current: $226.50
Upside: -18.32%
Jul 16, 2025
Downgrades: Neutral
Price Target: $394 → $410
Current: $477.10
Upside: -14.06%
May 13, 2025
Maintains: Buy
Price Target: $40 → $33
Current: $15.65
Upside: +110.86%
Oct 2, 2024
Downgrades: Underperform
Price Target: $3
Current: $0.54
Upside: +458.66%
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $136.79
Upside: +220.93%
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $9.33
Upside: -30.33%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $16.04
Upside: -54.80%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $271.33
Upside: +28.99%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $15.06
Upside: +198.80%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $3.01
Upside: +82.72%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $12.74
Upside: +174.73%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $2.35
Upside: +325.53%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $11.64
Upside: -35.57%
Jun 24, 2020
Initiates: Buy
Price Target: $18
Current: $28.11
Upside: -35.97%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $23.02
Upside: -
Feb 9, 2018
Maintains: Buy
Price Target: $23 → $19
Current: $27.71
Upside: -31.43%